UPB
Upstream Bio Inc.
$25.55
+$0.59(+2.36%)
61
Overall
60
Value
63
Tech
--
Quality
Market Cap
$1.38B
Volume
384.49K
52W Range
$5.14 - $26.90
Target Price
$52.33
Company Overview
| Mkt Cap | $1.38B | Price | $25.55 |
| Volume | 384.49K | Change | +2.36% |
| P/E Ratio | -22.0 | Open | $24.71 |
| Revenue | $2.4M | Prev Close | $24.96 |
| Net Income | $-62.8M | 52W Range | $5.14 - $26.90 |
| Div Yield | N/A | Target | $52.33 |
| Overall | 61 | Value | 60 |
| Quality | -- | Technical | 63 |
No chart data available
Latest News
3 Best Biotech Stocks to Buy Now, 11/12/2025, According to Top Analysts
Shalu Saraf•12 days ago
Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), Crispr Therapeutics AG (CRSP) and Upstream Bio, Inc. (UPB)
Catie Powers•12 days ago
Upstream Bio Reports Progress in Respiratory Trials
TipRanks Auto-Generated Newsdesk•18 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | UPB | $25.55 | +2.4% | 384.49K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |